The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
Open accessAbstract
Tumors are not merely masses of neoplastic cells but complex tissues composed of cellular and noncellular elements. This review provides recent data on the main components of a dynamic system, such as carcinoma associated fibroblasts that change the extracellular matrix (ECM) topology, induce stemness and promote metastasis-initiating cells. Altered production and characteristics of collagen, hyaluronan and other ECM proteins induce increased matrix stiffness. Stiffness along with tumor growth-induced solid stress and increased interstitial fluid pressure contribute to tumor progression and therapy resistance. Second, the role of immune cells, cytokines and chemokines is outlined. We discuss other noncellular characteristics of the tumor microenvironment such as hypoxia and extracellular pH in relation to neoangiogenesis. Overall, full understanding of the events driving the interactions between tumor cells and their environment is of crucial importance in overcoming treatment resistance and improving patient outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic of the biomechanical forces in the tumor microenvironment. As tumor cells proliferate they sequentially create new solid material (i.e. cells and matrix components) which generate radial and circumferential solid stresses. In the tumor center, circumferential and radial stresses are compressive while in the periphery, radial stress is compressive and circumferential stress is tensile (direction indicated with arrows). Compressive stresses in the tumor interior squeeze tumor components, including lymphatic and blood vessels (note compressed lumen of blood vessel and high density of cells and extracellular matrix in dark green). After the tumor is cut and the stresses are released, the tumor interior decompresses (note extended lumen of blood vessel, relaxed cells and extracellular matrix in light green). Reproduced and modified with permission from Prof. Rakesh K. Jain [55].](/paper-figures/1194c05f950c4cb6ad9845dd7d769c11/the-role-of-cancer-associated-fibroblasts-solid-stress-and-other-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“fibroblasts respond to a variety of chemotactic signals such as TGF-β, PDGF, and CXCL12, which are differentially distributed within tumors and further drive their directed migration toward tumor cores [286].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [286]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“FSP1 is proangiogenic, possibly mediated either by the activation of plasminogen or through the transcriptional upregulation of MMP13 [68].”
BackgroundKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“LOXL2 has been reported to be involved in invasiveness [27] and specifically expressed by fibroblasts in tumor tissue [28].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,330
Cited by
Sorted by citations
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
A peek into cancer-associated fibroblasts: origins, functions and translational impact
LeBleu, V. S., & Kalluri, R. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.029447 · Cited by 557
Goulet, C. R., Champagne, A., Bernard, G., Vandal, D., Chabaud, S., Pouliot, F., & Bolduc, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5353-6 · Cited by 333
Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 270
Defining the Role of Solid Stress and Matrix Stiffness in Cancer Cell Proliferation and Metastasis
Kalli, M., & Stylianopoulos, T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00055 · Cited by 267
Miyake, M., Hori, S., Morizawa, Y., Tatsumi, Y., Nakai, Y., Anai, S., Torimoto, K., Aoki, K., Tanaka, N., Shimada, K., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.08.002 · Cited by 230
Xiang, D., Shigdar, S. L., Qiao, G. G., Wang, T., Kouzani, A. Z., Zhou, S., Kong, L., Li, Y., Pu, C., & Duan, W. (2014) · Theranostics · doi:10.7150/thno.10202 · Cited by 223
Tumor Microenvironment Targeted Nanotherapy
Fernandes, C., Suares, D., & Yergeri, M. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01230 · Cited by 164
Giussani, M., Merlino, G., Cappelletti, V., Tagliabue, E., & Daidone, M. G. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.012 · Cited by 154
Redundant angiogenic signaling and tumor drug resistance
Gacche, R. N., & Assaraf, Y. G. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.002 · Cited by 140
The redox biology network in cancer pathophysiology and therapeutics
Manda, G., Isvoranu, G., Comanescu, M. V., Manea, A., BÜTÜNER, B. D., & Korkmaz, K. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.014 · Cited by 139
Fiber alignment drives changes in architectural and mechanical features in collagen matrices
Taufalele, P., VanderBurgh, J. A., Muñoz, A., Zanotelli, M. R., & Reinhart‐King, C. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216537 · Cited by 131
Smart polymers in drug delivery systems on crossroads: Which way deserves following?
Hrubý, M., Filippov, S. K., & Štěpánek, P. (2015) · European Polymer Journal · doi:10.1016/j.eurpolymj.2015.01.016 · Cited by 140
Lin, Z., Luo, G., Du, W., Kong, T., Liu, C., & Liu, Z. (2019) · Small · doi:10.1002/smll.201903899 · Cited by 134
The dark side of tumor-associated endothelial cells
Sanctis, F. D., Ugel, S., Facciponte, J. G., & Facciabene, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.002 · Cited by 137
Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment
Lara, R. P., & Annabi, N. (2016) · Lab on a Chip · doi:10.1039/c6lc00718j · Cited by 130
Chen, S., Yang, K., Tuguntaev, R. G., Mozhi, A., Zhang, J., Wang, P. C., & Liang, X. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.10.020 · Cited by 127
Yoshida, G. J., Azuma, A., Miura, Y., & Orimo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092256 · Cited by 131
Impact of the spheroid model complexity on drug response
Hoffmann, O. I., Ilmberger, C., Magosch, S., Joka, M., Jauch, K.-W., & Mayer, B. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.02.029 · Cited by 125
Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy
Gkretsi, V., Stylianou, A., Papageorgis, P., Polydorou, C., & Stylianopoulos, T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00214 · Cited by 127
Ultrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicine
Snipstad, S., Vikedal, K., Maardalen, M., Kurbatskaya, A., Sulheim, E., & Davies, C. D. L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113847 · Cited by 122
Oeyen, E., Hoekx, L., Wachter, S. D., Baldewijns, M. M. L. L., Ameye, F., & Mertens, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040821 · Cited by 123
Huang, M., Fu, M., Wang, J., Xia, C., Zhang, H., Xiong, Y., He, J., Liu, J., Liu, B., Pan, S., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114527 · Cited by 114
The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts
Mohr, A., & Zwacka, R. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.025 · Cited by 115
Compensatory angiogenesis and tumor refractoriness
Gacche, R. N. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.14 · Cited by 117
COX/mPGES-1/PGE 2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset
Larsson, K., Kock, A., Idborg, H., Arsenian‐Henriksson, M., Martinsson, T., Johnsen, J. I., Korotkova, M., Kogner, P., & Jakobsson, P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424355112 · Cited by 108
Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression
Wang, X., Qin, X., Yan, M., Shi, J., Xu, Q., Li, Z., Yang, W., Zhang, J., & Chen, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1144-9 · Cited by 99
Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts
Han, Y., Zhang, Y., Jia, T., & Sun, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3230-8 · Cited by 99
Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
Xu, S., Yang, Z., Jin, P., Yang, X., Li, X., Xiao, W., Wang, Y., Long, S., Zhang, T., Chen, G., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0927 · Cited by 100
Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration
Kalli, M., Papageorgis, P., Gkretsi, V., & Stylianopoulos, T. (2018) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-1997-7 · Cited by 98
Biomimetic tumor microenvironments based on collagen matrices
Sapudom, J., & Pompe, W. (2018) · Biomaterials Science · doi:10.1039/c8bm00303c · Cited by 91
Peela, N., Truong, D. D., Saini, H., Chu, H., Mashaghi, S., Ham, S. L., Singh, S. K., Tavana, H., Mosadegh, B., & Nikkhah, M. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.017 · Cited by 97
Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix
Kolosnjaj-Tabi, J., Marangon, I., Nicolas-Boluda, A., Silva, A. K. A., & Gazeau, F. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.010 · Cited by 86
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Lepareur, N., Ramée, B., Mougin‐Degraef, M., & Bourgeois, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061733 · Cited by 86
Tumor metabolism, cancer cell transporters, and microenvironmental resistance
Alfarouk, K. O. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1140753 · Cited by 88
Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
Fan, Y., Sun, Q., Li, X., Feng, J., Ao, Z., Li, X., & Wang, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.718834 · Cited by 82
Kim, B. G., Gao, M., Kang, S., Choi, Y. P., Lee, J. H., Kim, J. E., Han, H. H., Mun, S. G., & Cho, N. H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.73 · Cited by 80
Mieulet, V., Garnier, C., Kieffer, Y., Guilbert, T., Nemati, F., Marangoni, E., Renault, G., Chamming’s, F., Vincent-Salomon, A., & Mechta-Grigoriou, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-83685-0 · Cited by 79
Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
Cammarota, F., & Laukkanen, M. O. (2015) · Stem Cells International · doi:10.1155/2016/4824573 · Cited by 85
Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation
Olson, M. T., Ly, Q. P., & Mohs, A. M. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1239-2 · Cited by 79
Pan, M., Wang, H., Ansari, K. H., Li, X., Sun, W., & Fan, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01742-4 · Cited by 77
Alexa‐Stratulat, T., Pešić, M., Gašparović, A. Č., Trougakos, I. P., & Riganti, C. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100643 · Cited by 77
Aronovich, A., Moyal, L., Gorovitz, B., Amitay‐Laish, I., Naveh, H. P., Forer, Y., Maron, L., Knaneh, J., Ad‐El, D., Yaacobi, D. S., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.06.034 · Cited by 70
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Lee, S. W., Kwak, H. S., Kang, M.-H., Park, Y.-Y., & Jeong, G. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-20886-0 · Cited by 68
Xiong, Y., Wang, W., Deng, Q., Zhang, Z., Wang, Q., Yong, Z., Sun, C., Yang, X., & Li, Z. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101767 · Cited by 68
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
“In addition to hypoxia, fibroblasts respond to a variety of chemotactic signals such as TGF-β , PDGF, and CXCL12, which are differentially distributed within tumors and further drive their directed migration toward tumor cores [286].”
Li, J., Zhou, Y., Chen, W., Yuan, Z.-Q., You, B., Liu, Y., Yang, S.-D., Li, F., Qu, C., & Zhang, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b10679 · Cited by 66
Zheng, Z.-Y., Tian, L. H., Bu, W., Fan, C., Gao, X., Wang, H., Liao, Y., Li, Y., Lewis, M. T., Edwards, D. P., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.044 · Cited by 64
A TRACER 3D Co-Culture tumour model for head and neck cancer
Young, M. C., Rodenhizer, D., Dean, T., D’Arcangelo, E., Xu, B., Ailles, L., & McGuigan, A. P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.038 · Cited by 65
Saito, S., Morishima, K., Ui, T., Hoshino, H., Matsubara, D., Ishikawa, S., Aburatani, H., Fukayama, M., Hosoya, Y., Sata, N., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1065-8 · Cited by 60
Modulating tumor physical microenvironment for fueling CAR-T cell therapy
Luo, Z. Y., Yao, X., Li, M., Fang, D., Fei, Y., Cheng, Z., Xu, Y., & Zhu, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114301 · Cited by 59
Jiang, X., Xu, S., Miao, Y., Huang, K., Wang, B., Ding, B., Zhang, Z., Zhao, Z., Zhang, X., Shi, X., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319880121 · Cited by 57
3D cell coculture tumor model: A promising approach for future cancer drug discovery
Xin, X., Yang, H. K., Zhang, F., & Yang, S. (2018) · Process Biochemistry · doi:10.1016/j.procbio.2018.12.028 · Cited by 59
Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment
Longmate, W. M., & DiPersio, C. M. (2017) · F1000Research · doi:10.12688/f1000research.11877.1 · Cited by 57
Overcoming multiple drug resistance in cancer using polymeric micelles
Kesharwani, S. S., Kaur, S., Tummala, H., & Sangamwar, A. T. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1537261 · Cited by 57
Zhang, Y., Zhang, T., Wu, C., Xia, Q., & Xu, D. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.127 · Cited by 56
Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
Lior, C., Barki, D., Halperin, C., Iacobuzio–Donahue, C. A., Kelsen, D. P., & Scherz‐Shouval, R. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114236 · Cited by 59
CAFs‐derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling
Zhou, Z., Cui, D., Sun, M., Huang, J., Deng, Z., Han, B., Sun, X., Xia, S., Sun, F., & Shi, F. (2020) · The FASEB Journal · doi:10.1096/fj.201902659r · Cited by 54
Ansardamavandi, A., & Tafazzoli‐Shadpour, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119103 · Cited by 53
Alsibai, K. D., & Meseure, D. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24548 · Cited by 53
Digital microfluidics for spheroid-based invasion assays
Bender, B. F., Aijian, A. P., & Garrell, R. L. (2016) · Lab on a Chip · doi:10.1039/c5lc01569c · Cited by 49
Balachander, G. M., Talukdar, P. M., Debnath, M., Rangarajan, A., & Chatterjee, K. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b07609 · Cited by 49
Physical oncology: New targets for nanomedicine
Nicolás‐Boluda, A., Silva, A., Fournel, S., & Gazeau, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.014 · Cited by 48
Rudisch, A., Dewhurst, M. R., Horga, L. G., Kramer, N., Harrer, N. E., Dong, M., van der Kuip, H., Wernitznig, A., Bernthaler, A., Dolznig, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124283 · Cited by 47
Signaling by discoidin domain receptor 1 in cancer metastasis
Gadiya, M. M., & Chakraborty, G. (2018) · Cell Adhesion & Migration · doi:10.1080/19336918.2018.1520556 · Cited by 46
Cho, J., Lee, H., Hwang, S. J., Min, H., Kang, H. N., Park, A., Hyun, S. Y., Sim, J. Y., Lee, H. J., Jang, H.-J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0631 · Cited by 44
Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models
Haider, T., Sandha, K. K., Soni, V., & Gupta, P. N. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111229 · Cited by 44
Obstacles to T cell migration in the tumor microenvironment
Nicolás‐Boluda, A., & Donnadieu, E. (2018) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2018.12.006 · Cited by 45
Li, Y., Xiao, Z., Zhou, Y., Zheng, S., An, Y., Huang, W., He, H., Yang, Y., Li, S., Chen, Y., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b06439 · Cited by 43
Zakharia, Y., Bhattacharya, A., & Rustum, Y. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24297 · Cited by 43
Neri, S., Hashimoto, H., Kii, H., Watanabe, H., Masutomi, K., Kuwata, T., Date, H., Tsuboi, M., Goto, K., Ochiai, A., et al. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2046-7 · Cited by 40
Hhip regulates tumor-stroma-mediated upregulation of tumor angiogenesis
Agrawal, V., Kim, D. Y., & Kwon, Y. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.139 · Cited by 40
Yang, K., Wang, Y., Zhang, F., Li, Q., Luo, B., Feng, D., & Zeng, Z. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04436-x · Cited by 39
Baumgart, S., Hölters, S., Ohlmann, C., Bohle, R. M., Stöckle, M., Ostenfeld, M. S., Dyrskjøt, L., Junker, K., & Heinzelmann, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17619 · Cited by 39
Integrin Regulation of CAF Differentiation and Function
DiPersio, C. M., & Water, L. V. D. (2019) · Cancers · doi:10.3390/cancers11050715 · Cited by 39
Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy
Mbugua, S. N. (2022) · Bioinorganic Chemistry and Applications · doi:10.1155/2022/5041399 · Cited by 38
Carlessi, R., Köhn‐Gaone, J., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019 · Cited by 39
Singh, A., Nunes, J. J., & Ateeq, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.011 · Cited by 39
Atomic Force Microscopy Probing of Cancer Cells and Tumor Microenvironment Components
Stylianou, A., & Stylianopoulos, T. (2015) · BioNanoScience · doi:10.1007/s12668-015-0187-4 · Cited by 36
The dual role of asporin in breast cancer progression
Šimková, D., Kharaishvili, G., Kořínková, G., Oždian, T., Kleplová, T. S., Soukup, T., Křupka, M., Galandáková, A., Džubák, P., Janíková, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10471 · Cited by 34
Self-citationNeuroendocrine Factors in Melanoma Pathogenesis
Scheau, C., DRAGHICI, C. C., Ilie, M. A., Lupu, M., Solomon, I., Tampa, M. Ş., Georgescu, S. R., Căruntu, A., Constantin, C., Neagu, M. T., et al. (2021) · Cancers · doi:10.3390/cancers13092277 · Cited by 33
Stromal disruption facilitating invasion of a ‘nano-arsenal’ into the solid tumor
Fu, Y., Saraswat, A. L., Monpara, J. D., & Patel, K. R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.015 · Cited by 33
Sun, Y., Wang, R., Qiao, M., Yan-chun, X., Guan, W., & Wang, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26433 · Cited by 32
Wang, Y., Yao, B., Li, H., Zhang, Y., Gao, H., Gao, Y., Ruiyun, P., & Tang, J. (2017) · Journal of Ultrasound in Medicine · doi:10.7863/ultra.16.03066 · Cited by 32
Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells
Zhang, X., Schönrogge, M., Eichberg, J., Wendt, E. H. U., Kumstel, S., Stenzel, J., Lindner, T., Jaster, R., Krause, B. J., Vollmar, B., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00590 · Cited by 31
Wawro, M. E., Sobierajska, K., Ciszewski, W. M., & Niewiarowska, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081941 · Cited by 31
Wang, Y., Zhang, T., Guo, L., Ren, T., & Yang, Y. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.11.001 · Cited by 29
Yoon, N., Park, M. S., Shigemoto, T., Peltier, G. C., & Lee, R. H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.90 · Cited by 29
Cho, C., Horzempa, C., Jones, D., & McKeown‐Longo, P. J. (2016) · BMC Cancer · doi:10.1186/s12885-016-2621-6 · Cited by 29
NOTUM Is Involved in the Progression of Colorectal Cancer
Yoon, J. H., Kim, D., Kim, J. J., Lee, H., Ghim, J., KANG, B. J., Song, P., Suh, P., Ryu, S. H., & Lee, T. G. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20107 · Cited by 29
Feng, H., Cao, B., Peng, X., & Wei, Q. (2022) · BMC Cancer · doi:10.1186/s12885-022-09877-7 · Cited by 28
‘Two-faces’ of hyaluronan, a dynamic barometer of disease progression in tumor microenvironment
Liu, Y., Li, L., Wang, L., Lu, L., Li, Y., Huang, G., & Song, J. (2023) · Discover Oncology · doi:10.1007/s12672-023-00618-1 · Cited by 31
Goncharov, A. P., Vashakidze, N., & Kharaishvili, G. (2024) · Biomedicines · doi:10.3390/biomedicines12020418 · Cited by 28
Self-citationImmunotherapeutic Targeting of Tumor-Associated Blood Vessels
Fabian, K. P., & Storkus, W. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_13 · Cited by 29
Pogoda, K., Cieśluk, M., Deptuła, P., Tokajuk, G., Piktel, E., Król, G., Reszeć, J., & Bucki, R. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101105 · Cited by 27
Cancer-associated fibroblasts in papillary thyroid carcinoma
Zhu, L., Zhang, X., Zhang, S., Zhang, Q., Cao, L., Zhang, Y., Wang, D., Liang, X., Wu, W., Wu, S., et al. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-00998-2 · Cited by 26
The Interplay between Tumour Microenvironment Components in Malignant Melanoma
Amălinei, C., Grigoraş, A., Lozneanu, L., Căruntu, I.-D., Giuşcă, S. E., & Balan, R. A. (2022) · Medicina · doi:10.3390/medicina58030365 · Cited by 27
Azatov, M., Goicoechea, S. M., Otey, C. A., & Upadhyaya, A. (2016) · Scientific Reports · doi:10.1038/srep28805 · Cited by 25
Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer
Karta, J., Meyers, M., Rodriguez, F., Koncina, E., Gilson, C., Klein, E., Gabola, M., Benzarti, M., Escriva, P. P., Molina‐Tijeras, J. A., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00542-w · Cited by 26
Prasad, S., Chandra, A., Cavo, M., Parasido, E., Fricke, S., Lee, Y., D’Amone, E., Gigli, G., Albanese, C., Rodriguez, O., et al. (2020) · Nanotechnology · doi:10.1088/1361-6528/abc208 · Cited by 23
Metadata
- Authors
- Kharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., & Bouchal, J.
- Affiliations
- Institute of Molecular and Translational Medicine (CZ)
- University of Birmingham (GB)
- Corresponding author
- Bouchal, Jan
- Venue
- Cancer Cell International
- Published
- 2014-05-16
- Volume
- 14
- Issue
- 1
- Pages
- 41-41
- ISSN
- 1475-2867 (ISSN-L)
- PMC
- PMC4038849
- OpenAlex
- W2150704193
- Cited by
- 197
- References
- 110
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 11 · 2023: 12 · 2022: 14 · 2021: 11 · 2020: 8 · 2019: 22 · 2018: 27 · 2017: 19 · 2016: 20 · 2015: 34 · 2014: 3
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Cancer Cell International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, extracellular matrix stiffness, solid stress, interstitial fluid pressure, treatment resistance, tumor progression, metastasis-initiating cells, stemness, collagen, hyaluronic acid, tumor hypoxia, extracellular pH, neoangiogenesis, immune cells, cytokines, chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
